Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Xenikos Presents Promising New Data from Expanded Access Program (EAP) Using T-Guard to Treat Steroid-Refractory Acute GVHD at ASH Annual Meeting

firstwordpharmaDecember 10, 2019

Tag: Xenikos , T-Guard , Steroid-Refractory Acute GVHD

PharmaSources Customer Service